Drugs / IFN-Y
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01374711 Comparator | May → Nov 2011 | infectious disease with sepsis, multiple organ dysfunction syndrome | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-Y | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01374711 ↗ |
| Known as | IFN-γ | “Although IFN-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF) restore immune competence of ex vivo stimulated leukocytes of patients with sepsis, effects on...” PMID 22822024 ↗ Jul 2012 |
| Route | Subcutaneous | “On days 2, 4, and 6, subjects received subcutaneous injections of IFN-γ (100 μg/day; n = 6), GM-CSF (4 μg/kg/day; n = 6), or placebo (NaCl 0.9%; n = 6).” PMID 22822024 ↗ Jul 2012 |